StockWatch
·

Aarti Pharmalabs Ltd

BSE: 543748

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-51.39186.41424.22662.02Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
4.4112.9321.4529.97Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
PeriodQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue534.59-7.8%579.70+36.3%425.25+1.9%417.29+11.2%375.31-29.1%529.62+12.5%470.95+24.8%377.29
Other Income2.93-72.2%10.53+2936.8%-0.37-111.8%3.15+97.3%1.60+163.7%-2.50-121.0%11.94+305.0%2.95
Total Income537.52-8.9%590.23+38.9%424.88+1.1%420.44+11.5%376.91-28.5%527.12+9.2%482.88+27.0%380.24
EXPENSES
Expenditure441.30-13.1%507.65+39.7%363.51-4.0%378.74+22.3%309.73-25.1%413.62+7.0%386.70+22.1%316.81
Tax24.92+21.2%20.55+39.5%14.74+36.8%10.77-32.5%15.95-35.3%24.66+8.8%22.66+45.3%15.60
PROFIT
PBT96.22+16.5%82.59+41.0%58.58+40.5%41.70-37.9%67.17-40.8%113.50+18.0%96.18+51.6%63.43
Net Profit71.31+15.0%62.03+41.5%43.84+41.8%30.93-39.6%51.22-42.3%88.85+20.8%73.52+53.7%47.84
KEY METRICS
OPM %25.48%+5.28pp20.20%-3.35pp23.55%+5.82pp17.73%-7.62pp25.35%-1.67pp27.02%+15.66pp11.36%+1.77pp9.59%
NPM %13.27%+2.76pp10.51%+0.19pp10.32%+2.96pp7.36%-6.23pp13.59%-3.26pp16.85%+1.62pp15.23%+2.65pp12.58%
EPS7.87+15.1%6.84+41.3%4.84+41.9%3.410.00-100.0%9.80+20.8%8.11+53.6%5.28

Corporate Events

Board MeetingAARTIPHARM
2026
22Sep

Board Meeting

The Company has also initiated sending letters containing th…

BSE Filing ↗
DividendAARTIPHARM
2026
15Sep

₹2 / share

BSE Filing ↗
Board MeetingAARTIPHARM
2026
7Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingAARTIPHARM
2026
25May

Board Meeting

The Board Meeting was held on May 25, 2026. The agenda incl…

BSE Filing ↗
DividendAARTIPHARM
2026
16Feb

₹1.5 / share

BSE Filing ↗
DividendAARTIPHARM
2025
15Sep

₹2.5 / share

BSE Filing ↗
DividendAARTIPHARM
2025
14Feb

₹5 / share

BSE Filing ↗
Board MeetingAARTIPHARM
2024
28Oct

Board Meeting

Audited Financial Results

BSE Filing ↗
Board MeetingAARTIPHARM
2024
13May

Board Meeting

Consider and approve Audited Financial Results for the quart…

BSE Filing ↗
DividendAARTIPHARM
2024
19Feb

₹2 / share

BSE Filing ↗
DividendAARTIPHARM
2024
7Feb

₹2 / share

BSE Filing ↗
Board MeetingAARTIPHARM
2024
7Feb

Board Meeting

Consider and approve Audited Financial Results for the quart…

BSE Filing ↗
Board MeetingAARTIPHARM
2023
7Nov

Board Meeting

Consider and approve Audited Financial Results for the quart…

BSE Filing ↗